ClinicalTrials.gg
Not yet recruitingNCT07792330Updated Aug 28, 2026

Asthma Lung Sounds With Wearable Stethoscope

An interventional study of Prototype Wearable Stethoscope in Asthma, Pediatric Asthma and Airway Obstruction Upper, sponsored by Children's Hospital Los Angeles. Not yet recruiting at 1 site in United States. Open to participants aged 4 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-08-28.

Sponsored by Children's Hospital Los Angeles · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
4 Years to 17 Years
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate a prototype wearable stethoscope designed to record lung sounds and assess asthma control in children and adolescents with asthma aged 4 to 17 years who are able to perform spirometry. The study aims to determine whether the prototype wearable stethoscope can accurately detect clinically meaningful changes in lung sounds associated with asthma control and response to bronchodilator treatment.

The main questions it aims to answer are:

  • Does the prototype wearable stethoscope demonstrate agreement with recordings obtained from commercially available Thinklabs One Digital Stethoscopes in identifying normal and abnormal lung sounds?
  • Are lung sounds detected by the prototype wearable stethoscope associated with asthma symptom control as measured by the Childhood Asthma Control Test (cACT) or Asthma Control Test (ACT)

Researchers will compare recordings obtained from the prototype wearable stethoscope with recordings obtained from FDA-cleared Thinklabs One Digital Stethoscopes to evaluate the prototype device's ability to detect abnormal lung sounds and changes in lung sounds following bronchodilator treatment.

02

Conditions studied

  • Asthma
  • Pediatric Asthma
  • Airway Obstruction Upper

Browse trials for

Keywords

  • Wearable Stethoscope
  • Asthma
  • Lung Sound Monitoring
03

In context

Asthma

4,841 studies on the registry are indexed under Asthma; 600 are open to participants now.

This study's planned enrollment of 50 is below the median of 78 across 3,341 interventional studies indexed under Asthma.

Browse Asthma studies →

Lead sponsor

Children's Hospital Los Angeles is the lead sponsor of 152 studies on the registry; 46 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 6 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children and adolescents aged 4 to 17 years
  • Diagnosis of asthma
  • Ability to perform spirometry
  • Assent (as applicable) and parental/legal guardian permission obtained

Exclusion criteria

Exclusion Criteria:

  • Unable to follow spirometry procedures
  • Intubated at the time of enrollment
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Prototype Wearable Stethoscope Evaluation

    Participants aged 4 to 17 years with asthma will complete asthma control questionnaires, undergo pre- and post-bronchodilator spirometry, and have lung sounds recorded simultaneously using a prototype wearable stethoscope and four Thinklabs One Digital Stethoscopes. Lung sound recordings obtained before and after bronchodilator administration will be used to evaluate agreement between devices and assess associations between detected lung sounds, lung function, and asthma control

    Device: Prototype Wearable Stethoscope

Interventions

  • DevicePrototype Wearable Stethoscope

    The Prototype Wearable Stethoscope is a wireless device used to record lung sounds in children with asthma. Recordings will be compared with a standard digital stethoscope to evaluate device performance.

06

What researchers measure

Primary outcomes

  1. Agreement Between Prototype Wearable Stethoscope and Thinklabs One Digital Stethoscope

    Agreement between the prototype wearable stethoscope and the FDA-cleared Thinklabs One Digital Stethoscope in the classification of normal versus abnormal lung sounds, assessed using Cohen's Kappa.

    Time frame: Single study visit (up to 90 minutes).

  2. Association Between Lung Sounds and Asthma Control Scores

    Association between abnormal lung sounds detected by the prototype wearable stethoscope and asthma control as measured by the Childhood Asthma Control Test (cACT) or Asthma Control Test (ACT).

    Time frame: Single study visit (up to 90 minutes).

Secondary outcomes

  1. Sensitivity of Abnormal Lung Sound Detection

    Sensitivity of the prototype wearable stethoscope for detecting abnormal lung sounds compared with Thinklabs One Digital Stethoscope recordings

    Time frame: Single study visit (up to 90 minutes).

  2. Specificity of Abnormal Lung Sound Detection

    Specificity of the prototype wearable stethoscope for detecting abnormal lung sounds compared with Thinklabs One Digital Stethoscope recordings

    Time frame: Single study visit (up to 90 minutes).

  3. Positive Predictive Value (PPV)

    Positive predictive value of the prototype wearable stethoscope for identifying abnormal lung sounds compared with Thinklabs One Digital Stethoscope recordings.

    Time frame: Single study visit (up to 90 minutes).

  4. Negative Predictive Value (NPV)

    Negative predictive value of the prototype wearable stethoscope for identifying abnormal lung sounds compared with Thinklabs One Digital Stethoscope recordings.

    Time frame: Single study visit (up to 90 minutes).

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07792330
Responsible party
Roberta Kato (Medical Staff/USC Faculty CWR, Children's Hospital Los Angeles) — Principal investigator
First posted
Aug 28, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Jul 30, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Aug 28, 2026

Study contacts

Danny Del Cid-Linares
Contact
ddelcidlinares@chla.usc.edu
310-445-0919
Roberta Kato, MD
principal investigator · Children's Hospital Los Angeles

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion